Albert D. Dyrness - 30 May 2023 Form 4 Insider Report for Sonnet BioTherapeutics Holdings, Inc. (SONN)

Role
Director
Signature
/s/ John Harry Cross III, power of attorney
Issuer symbol
SONN
Transactions as of
30 May 2023
Transactions value $
$10,883
Form type
4
Filing time
31 May 2023, 08:30:14 UTC
Previous filing
22 Dec 2022
Next filing
05 Dec 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SONN Common Stock Purchase $10,883 +23,255 +4.07% $0.468* 28,962 30 May 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes unvested RSUs.